Skip to main content

Table 1 Demographic characteristics and baseline data of subjects

From: Effects of oral oligopeptide preparation and exercise intervention in older people with sarcopenia: a randomized controlled trial

 

Control group(n = 46)

Exercise group(n = 35)

Nutrition group(n = 48)

Combined group(n = 30)

P value

Age(years)[ \(\overline{{\varvec{x}} }\)(s)]

73.21(4.98)

72.04(5.02)

72.68(5.59)

70.52(3.30)

0.209

Gender(female%)

22(47.8%)

19(54.3%)

23(47.9%)

14(46.7%)

0.918

Baseline data[ \(\overline{{\varvec{x}} }\)(s)]

 Body weight(kg)

49.54 (7.02)

46.59 (6.70)

49.18 (7.36)

51.52 (6.43)

0.105

 BMI (kg/m2)

21.86(2.57)

21.47(3.45)

21.49(2.80)

22.53(2.28)

0.526

 Left grip strength(kg)

21.02(6.84)

19.52(3.75)

21.92(6.41)

21.91(6.21)

0.391

 Right grip strength(kg)

20.50(5.27)

20.11(3.73)

23.78(6.85)* #

23.06(7.05)

0.044

 6-m walking speed(m/s)

0.92(0.18)

0.99(0.17)

0.96(0.23)

1.05(0.18)

0.139

 SMM (kg)

17.40(3.29)

16.51(2.19)

17.93(3.58)

18.05(3.10)

0.260

 SMI (kg)

5.54(0.75)

5.40(0.52)

5.56(0.82)

5.71(0.77)

0.524

 MNA-SF score

12.75(1.16)

12.85(0.99)

12.59(1.12)

13.08(0.95)

0.666

Disease history[n(%)]

 Hypertension

14(30.43%)

11(31.43%)

14(29.17%)

10(33.33%)

0.984

 Diabetes mellitus

9(19.57%)

9(25.71%)

12(25.00%)

5(16.67%)

0.756

 Lipid abnormality

8(17.39%)

8(22.86%)

10(20.83%)

4(13.33%)

0.765

 Osteoporosis

1(2.17%)

1(2.86%)

1(2.08%)

2(6.67%)

0.729

 Fracture history

3(6.52%)

4(11.43%)

3(6.25%)

2(6.67%)

0.858

  1. *The difference was statistically significant (P < 0.05) compared with the control group
  2. #The difference was statistically significant (P < 0.05) compared with the exercise group